Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group. - Crump,M.; Tu,D.; Shepherd,L.; Levine,M.; Bramwell,V.; Pritchard,K. (J Clin Oncol, 2003)